NCT07919860
Observation Study on the Efficacy and Safety of Hepatic Artery Embolization Combined With Radiofrequency Ablation for Hepatic Hemangioma: The Impact of Different Treatment Intervals
StatusNot Yet Recruiting
PhaseNot specified
SponsorBeijing Tiantan Hospital
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Tumour volume reduction rate
Timeframe: 6 month and 12 month post RFA
Secondary (1)
Peri-procedural complication incidence
Arms and interventions
Short-interval group
RFA is performed at 10-14 days after TAE
Long-interval group
RFA is performed at 2-3 months after TAE
Procedures: transcatheter arterial embolization (TAE), radiofrequency ablation (RFA)